High Court Won't Hear J&J Appeal Of $140M Motrin Verdict
Law360, New York (January 19, 2016, 2:16 PM EST) -- The U.S. Supreme Court on Tuesday declined to review a $140 million jury verdict over inadequate warnings on Johnson & Johnson's Children's Motrin in favor of a teenager who had developed a life-threatening skin condition, which had been upheld by Massachusetts' highest court.
The nation's high court, as customary, didn't comment on why it decided to deny Johnson & Johnson's petition for writ of certiorari. The pharmaceutical giant had argued in its Oct. 8 petition that claims by Samantha Reckis and her parents that J&J's Children's Motrin gave Reckis a horrific skin condition, requiring multiple hospital stays and surgeries since she...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!